Evidence map›Paper›PMID 32038561›Full record

ArticleFrontiers in microbiology2019

The

Blair Armistead, Christopher Whidbey, Lakshminarayan M Iyer, Pilar Herrero-Foncubierta, Phoenicia Quach, Ali Haidour, L Aravind, Juan Manuel Cuerva, Heather B Jaspan, Lakshmi Rajagopal

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Antimicrobial Resistance and Virulence Factor ofInfection and drug resistance · 2021
    Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 3 countries.

Blair ArmisteadDepartment of Global Health, University of Washington, Seattle, WA, United States.
Christopher WhidbeyDepartment of Global Health, University of Washington, Seattle, WA, United States.
Lakshminarayan M IyerComputational Biology Branch, National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD, United States.
Pilar Herrero-FoncubiertaDepartment of Organic Chemistry, University of Granada, Granada, Spain.
Phoenicia QuachCenter for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States.
Ali HaidourDepartment of Organic Chemistry, University of Granada, Granada, Spain.
L AravindComputational Biology Branch, National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD, United States.
Juan Manuel CuervaDepartment of Organic Chemistry, University of Granada, Granada, Spain.
Heather B JaspanDepartment of Global Health, University of Washington, Seattle, WA, United States.
Lakshmi RajagopalDepartment of Global Health, University of Washington, Seattle, WA, United States.
Universidad de Granada · ESInfectious Disease Research Institute · USUniversity of Washington · USNational Center for Biotechnology Information · USNational Institutes of Health · USUniversity of Cape Town · ZA

Funding

Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Role of the hyaluronidase in GBS VirulenceR01AI133976 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2017 to 2021
$4.5M
GBS mediated in utero fetal injuryR01AI100989 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI ADAMS WALDORF, KRISTINA M., RAJAGOPAL, LAKSHMI · 2012 to 2016
$3.9M
Role of an ornithine rhamnolipid pigment in GBS virulenceR01AI112619 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2014 to 2018
$2.4M
Role of human cervical mucus plugs in ascending GBS infectionR21AI125907 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI RAJAGOPAL, LAKSHMI · 2016 to 2017
$538k
NIAID NIH HHS R01 AI100989NIAID NIH HHS R01 AI112619NIAID NIH HHS R01 AI133976NIAID NIH HHS R21 AI125907NIAID NIH HHS T32 AI007509
6 · The paper itself

Abstract

Group B

Indexed as

bacterial toxinGram-positive bacteriaGroup B Streptococcusmicrobial evolutionvirulence factor

Identifiers

PMID32038561
PMCPMC6985545
OpenAlexW3002887921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.